Inci Alacacioglu
Overview
Explore the profile of Inci Alacacioglu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
203
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Payzin K, Savasoglu K, Alacacioglu I, Dalgic E, Bolat Kucukzeybek B, Calli A, et al.
Clin Lymphoma Myeloma Leuk
. 2020 Sep;
21(2):125-131.
PMID: 32919926
Purpose: To assess the prevalence of PHT in patients with BCR-ABL1-negative CMPN and to evaluate impact of PHT on survival during long-term follow-up. Patients And Methods: A total of 122...
12.
Beksac M, Aydin Y, Goker H, Turgut M, Kalayoglu Besisik S, Cagirgan S, et al.
Clin Lymphoma Myeloma Leuk
. 2020 Jun;
20(8):e474-e484.
PMID: 32482539
Background: In countries where frontline drug approval is limited to first-generation proteasome inhibitors or immunomodulatory drugs, relapses have been both more frequent and less durable. We investigated real world data...
13.
Cekdemir D, Guvenc S, Ozdemirkiran F, Eser A, Toptas T, Ozkocaman V, et al.
Turk J Haematol
. 2019 Jul;
36(4):230-237.
PMID: 31327186
Objective: The aim of the present study was to evaluate the efficacy and safety of eltrombopag, an oral thrombopoietin receptor agonist, in patients with chronic immune thrombocytopenia (ITP). Materials And...
14.
Adiyaman S, Alacacioglu I, Danyeli A, Turkyilmaz D, Sevindik O, Demirkan F, et al.
Turk J Haematol
. 2019 Feb;
36(2):81-87.
PMID: 30724061
Objective: Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL). The treatment of older NHL patients has always been a struggle; however, treatment statistics have...
15.
Solmaz S, Uzun O, Acar C, Sevindik O, Piskin O, Ozsan H, et al.
J Lab Physicians
. 2018 Dec;
10(4):363-369.
PMID: 30498304
Background: Recent reports showed neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR), as a predictor of progression-free survival (PFS) and overall survival (OS) in various malignancies. Materials And...
16.
Erdem M, Tufekci O, Yilmaz S, Alacacioglu I, Oren H
Acta Haematol
. 2018 Nov;
141(1):28-31.
PMID: 30472699
Dyskeratosis congenita (DC) is a rare inherited syndrome characterized by classical mucocutaneous features and the presence of other clinical features including bone marrow failure, pulmonary fibrosis, liver cirrhosis, and a...
17.
Solmaz S, Kahraman S, Sevindik O, Acar C, Turkyilmaz M, Alacacioglu I, et al.
Indian J Hematol Blood Transfus
. 2018 Oct;
34(4):677-683.
PMID: 30369740
Peripheral blood is the prefered source for hematopoietic stem cells for hematopoietic stem cell transplantation. The efficiency of peripheral blood stem cell (PBSC) collection can vary among devices. In this...
18.
Solmaz Medeni S, Acar C, Olgun A, Acar A, Seyhanli A, Taskiran E, et al.
Clin Transplant
. 2018 Jul;
32(9):e13359.
PMID: 30053318
Background: Recent reports have showed that neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR) are predictors of progression-free survival (PFS) and overall survival (OS) in many types of...
19.
Solmaz Medeni S, Turkyilmaz D, Acar C, Sevindik O, Yuksel F, Piskin O, et al.
Turk J Haematol
. 2018 Jun;
35(4):271-276.
PMID: 29923493
Objective: High-doses of melphalan treatment with autologous stem cell transplantation in multiple myeloma (MM) remains a major treatment modality in suitable patients. A minimal dose of 2x10/kg CD34+ cells is...
20.
Tekgunduz E, Yilmaz M, Erkurt M, Kiki I, Kaya A, Kaynar L, et al.
Transfus Apher Sci
. 2018 Mar;
57(1):27-30.
PMID: 29503132
Thrombotic microangiopathies (TMAs) are rare, but life-threatening disorders characterized by microangiopathic hemolytic anemia and thrombocytopenia (MAHAT) associated with multiorgan dysfunction as a result of microvascular thrombosis and tissue ischemia. The...